Stockreport

Immunocore: Pipeline Expands HLA Tumor Targeting Beyond Kimmtrak [Seeking Alpha]

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF Follow Summary In Q2 of 2024, sales of Kimmtrak were $75 million, which was a year-over-year increase of 32%. Two expansion opportunities are possible for Kimmtra [Read more]